We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Leader Challenges Selection of Reagan-Udall Foundation Member
House Leader Challenges Selection of Reagan-Udall Foundation Member
December 7, 2007
An influential member of Congress is using the recent controversy concerning intimidation tactics GlaxoSmithKline (GSK) allegedly used to prevent a researcher from making public statements questioning the safety of Avandia to underline her concerns with the Reagan-Udall Foundation.